Nephron Pharmaceuticals Corporation 401(K) Savings Plan — Form 5500 plan (Nephron Pharmaceuticals Corp.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Nephron Pharmaceuticals Corporation 401(K) Savings Plan is a benefit plan reported by Nephron Pharmaceuticals Corp. under EIN 93-1065757 and plan number 001. The latest loaded filing year is 2023. The filing reports 3,927 participants and $16,030,958 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Nephron Pharmaceuticals Corp.
EIN
93-1065757
Plan number
001
Plan type
2
Location
West Columbia, SC
Latest filing year
2023
Participants
3,927
End-of-year plan assets
$16,030,958

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20233,927H, C20260105150704NAL0007324178001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$16,030,958
Total liabilities (EOY)
$0
Net assets (EOY)
$16,030,958
Net assets (BOY)
$14,294,392

Income & contributions

Employer contributions
$792,125
Participant contributions
$2,221,225
Total contributions
$3,044,010
Total income / additions
$5,575,008

Expenses & distributions

Benefits paid
$3,694,337
Administrative expenses
$144,105
Total expenses
$3,838,442
Net increase / (decrease)
$1,736,566

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Empower Annuity Insurance Company ORECORDKEEPER$101,745$02023
Morgan StanleyINVESTMENT ADVISOR$41,696not reported in the loaded dataset2023
Empower Advisory Group, LLCINVESTMENT MGMT$364not reported in the loaded dataset2023
Qdro Consultants Company, LLCOTHER$300not reported in the loaded dataset2023

Related Form 5500 pages